Stay updated on Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:32:17.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has removed detailed information about a study on short course Daratumumab for Multiple Myeloma, including its purpose, inclusion and exclusion criteria, and specific patient requirements. Additionally, it has added the name of the study's collaborators and updated the version number.
    Difference
    35%
    Check dated 2025-04-16T20:53:05.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T16:09:04.000Z thumbnail image
  5. Check
    37 days ago
    No Change Detected
  6. Check
    51 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-18T14:54:55.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-11T08:55:46.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T23:22:24.000Z thumbnail image

Stay in the know with updates to Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.